Rapid Autopsy Program for Small Cell Lung Cancer

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Recruiting Observational Study
Small Cell Lung Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Indiana University · Other
Who this trial is looking for

This trial is looking for patients with small cell lung cancer who are 18 years or older. Participants will provide consent to help establish a program for collecting tumor tissue after death.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years or older.
  • I have been diagnosed with small cell lung cancer.
  • I have given written consent for my health information to be used.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. ≥ 18 years old at the time of informed consent 2. Written informed consent and HIPAA authorization for release of personal health information. 3. Active SCLC diagnosis.
Contacts

Gabby Kline, BA

(317) 278-2514

gabkline@iu.edu

CONTACT

Shadia I. Jalal, MD

317-274-3589

sjalal@iu.edu

CONTACT